New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
12:26 EDTZMHZimmer down slightly after FDA recalls PEEK Ardis Inserter
The FDA announced that it was issuing a Class I recall for Zimmer Spine's (ZMH) PEEK Ardis Inserter. A Class I recall is issued when the FDA believes that there is a reasonable probability that the use of a product could cause serious health problems. The device is used to insert Zimmer's PEEK Ardis Interbody Spacer during spinal surgery. Zimmer was told that the spacer has broken into fragments when too much lateral force is applied to the inserter in some cases, the FDA reported. As a result, patients may experience various adverse effects, including a tear in the thin covering of the spinal cord, cerebrospinal fluid leakage, significant blood loss and nerve injury, according to the agency. Long-term health risks may include disability, dysfunction, or death, it added. The FDA's recall was initiated on December 21. Zimmer, on December 20, had initiated a voluntary recall of all 315 of its PEEK inserter units. Zimmer said at that time that it had received reports of the spacer implant breaking, but did not list adverse health effects that could occur if the implant breaks. In early afternoon trading, Zimmer fell 38c, or 0.57%, to $66.35.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:12 EDTZMHAmerican Academy of Orthopedic Surgeons to hold annual meeting
Subscribe for More Information
07:02 EDTZMHZimmer announces clearance by Japan FTC of pending Biomet merger
Subscribe for More Information
March 18, 2015
12:06 EDTZMHEU set to conditionally approve Zimmer, Biomet deal, Reuters reports
The European Union is set to give conditional approval to Zimmer's proposed acquisition of Biomet, Reuters reports, citing two people with knowledge of the matter. Reference Link
10:52 EDTZMHZimmer deal for Biomet unlikely delayed by DPA, says Piper Jaffray
Subscribe for More Information
10:46 EDTZMHZimmer says DOJ extended Biomet DPA for another year
Subscribe for More Information
March 16, 2015
08:05 EDTZMHZimmer announces first clinical use of Vivacit-E liner
Zimmer announced its first reverse shoulder replacement in the United States using Vivacit-E Liner for the Trabecular Metal Reverse Shoulder System.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use